RaySearch Laboratories AB (publ) (RAY-B.ST)
SEK 205.0
(1.49%)
SEK 205.0
(1.49%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 114.88 Million SEK | 181.3% |
| 2022 | 42.74 Million SEK | 181.21% |
| 2021 | -52.63 Million SEK | -6631.07% |
| 2020 | -782 Thousand SEK | -101.15% |
| 2019 | 68.16 Million SEK | -2.07% |
| 2018 | 69.6 Million SEK | -56.4% |
| 2017 | 159.66 Million SEK | -19.99% |
| 2016 | 199.55 Million SEK | 109.3% |
| 2015 | 95.34 Million SEK | 20.14% |
| 2014 | 79.36 Million SEK | 408.54% |
| 2013 | -25.72 Million SEK | -214.08% |
| 2012 | 22.54 Million SEK | -18.38% |
| 2011 | 27.62 Million SEK | -30.72% |
| 2010 | 39.87 Million SEK | -2.42% |
| 2009 | 40.86 Million SEK | 94.05% |
| 2008 | 21.05 Million SEK | -18.32% |
| 2007 | 25.78 Million SEK | -23.13% |
| 2006 | 33.54 Million SEK | -15.32% |
| 2005 | 39.6 Million SEK | 167.54% |
| 2004 | 14.8 Million SEK | 577.86% |
| 2003 | -3.09 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 80 Million SEK | 91.49% |
| 2024 Q1 | 41.42 Million SEK | -12.05% |
| 2023 FY | 120.24 Million SEK | 181.3% |
| 2023 Q3 | 28.61 Million SEK | 57.01% |
| 2023 Q2 | 18.22 Million SEK | -23.02% |
| 2023 Q1 | 23.67 Million SEK | 14.38% |
| 2023 Q4 | 47.09 Million SEK | 64.59% |
| 2022 Q4 | 20.7 Million SEK | 23.93% |
| 2022 Q2 | -19.52 Million SEK | -166.05% |
| 2022 Q1 | 29.56 Million SEK | 278.33% |
| 2022 FY | 42.74 Million SEK | 181.21% |
| 2022 Q3 | 16.7 Million SEK | 185.54% |
| 2021 Q3 | -26.56 Million SEK | -18.24% |
| 2021 FY | -52.63 Million SEK | -6631.07% |
| 2021 Q1 | 12.26 Million SEK | 184.03% |
| 2021 Q4 | -16.57 Million SEK | 37.59% |
| 2021 Q2 | -22.46 Million SEK | -283.21% |
| 2020 Q2 | -10.95 Million SEK | -121.25% |
| 2020 Q1 | 51.55 Million SEK | 129.47% |
| 2020 Q4 | -14.59 Million SEK | 50.5% |
| 2020 FY | -782 Thousand SEK | -101.15% |
| 2020 Q3 | -29.47 Million SEK | -169.1% |
| 2019 Q3 | -6.34 Million SEK | -122.02% |
| 2019 Q2 | 28.8 Million SEK | 23.98% |
| 2019 Q4 | 22.46 Million SEK | 454.11% |
| 2019 FY | 68.16 Million SEK | -2.07% |
| 2019 Q1 | 23.23 Million SEK | 38.13% |
| 2018 FY | 69.6 Million SEK | -56.4% |
| 2018 Q4 | 16.82 Million SEK | 35.44% |
| 2018 Q3 | 12.42 Million SEK | -52.7% |
| 2018 Q2 | 26.25 Million SEK | 86.12% |
| 2018 Q1 | 14.1 Million SEK | -85.71% |
| 2017 FY | 159.66 Million SEK | -19.99% |
| 2017 Q1 | 33.46 Million SEK | -66.62% |
| 2017 Q3 | 666 Thousand SEK | -97.52% |
| 2017 Q2 | 26.83 Million SEK | -19.8% |
| 2017 Q4 | 98.69 Million SEK | 14719.52% |
| 2016 Q1 | 23.35 Million SEK | -47.29% |
| 2016 FY | 199.55 Million SEK | 109.3% |
| 2016 Q2 | 37.49 Million SEK | 60.56% |
| 2016 Q3 | 38.46 Million SEK | 2.59% |
| 2016 Q4 | 100.24 Million SEK | 160.62% |
| 2015 FY | 95.34 Million SEK | 20.14% |
| 2015 Q3 | 20.08 Million SEK | 1050.09% |
| 2015 Q4 | 44.3 Million SEK | 120.57% |
| 2015 Q2 | -2.11 Million SEK | -106.39% |
| 2015 Q1 | 33.07 Million SEK | -37.33% |
| 2014 Q2 | 2.14 Million SEK | 353.79% |
| 2014 FY | 79.36 Million SEK | 408.54% |
| 2014 Q4 | 52.76 Million SEK | 189.53% |
| 2014 Q3 | 18.22 Million SEK | 750.84% |
| 2014 Q1 | -844 Thousand SEK | -307.88% |
| 2013 Q4 | 406 Thousand SEK | 102.71% |
| 2013 FY | -25.72 Million SEK | -214.08% |
| 2013 Q3 | -15 Million SEK | 21.98% |
| 2013 Q2 | -19.23 Million SEK | -337.14% |
| 2013 Q1 | 8.11 Million SEK | -69.08% |
| 2012 Q1 | 6.71 Million SEK | -54.12% |
| 2012 Q3 | -446 Thousand SEK | 95.52% |
| 2012 Q2 | -9.95 Million SEK | -248.23% |
| 2012 FY | 22.54 Million SEK | -18.38% |
| 2012 Q4 | 26.23 Million SEK | 5981.61% |
| 2011 Q2 | -119 Thousand SEK | -105.71% |
| 2011 Q3 | 11.01 Million SEK | 9357.98% |
| 2011 Q4 | 14.64 Million SEK | 32.91% |
| 2011 FY | 27.62 Million SEK | -30.72% |
| 2011 Q1 | 2.08 Million SEK | -86.45% |
| 2010 Q4 | 15.37 Million SEK | 1982.79% |
| 2010 FY | 39.87 Million SEK | -2.42% |
| 2010 Q3 | 738 Thousand SEK | -94.11% |
| 2010 Q2 | 12.52 Million SEK | 11.4% |
| 2010 Q1 | 11.24 Million SEK | -52.79% |
| 2009 Q1 | 9.85 Million SEK | 0.0% |
| 2009 Q3 | 445 Thousand SEK | -93.41% |
| 2009 FY | 40.86 Million SEK | 94.05% |
| 2009 Q4 | 23.81 Million SEK | 5251.01% |
| 2009 Q2 | 6.75 Million SEK | -31.44% |
| 2008 FY | 21.05 Million SEK | -18.32% |
| 2007 FY | 25.78 Million SEK | -23.13% |
| 2006 FY | 33.54 Million SEK | -15.32% |
| 2005 FY | 39.6 Million SEK | 167.54% |
| 2004 FY | 14.8 Million SEK | 577.86% |
| 2003 FY | -3.09 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aino Health AB (publ) | -9.51 Million SEK | 1307.611% |
| Bonzun AB (publ) | -25.25 Million SEK | 554.881% |
| Kontigo Care AB (publ) | 52 Thousand SEK | -220823.077% |
| Medhelp Care Aktiebolag (publ) | -10.48 Million SEK | 1195.765% |
| Surgical Science Sweden AB (publ) | 191.28 Million SEK | 39.944% |